Sign in

CIK 0001561921

  • Non-accelerated filer
  • Smaller reporting company

TELA Bio, Inc.

Sign in to watch
Ticker
TELA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455320061
Phone
+1 484-320-2930
Business address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
Open-market buys, last 90 days
$167,238
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$167,238. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Capper Joseph H +$167K Director 2 filings
Date Insider Transaction Shares Price Value Owned after
2019-11-13 Azarbarzin Kurt Director Conversion · Series B Preferred Stock −5,377,928 0
2019-11-13 Azarbarzin Kurt Director Conversion · Series B Preferred Stock −72,417 0
2019-11-13 Azarbarzin Kurt Director Conversion · Warrant (right to buy) −123,653 0
2019-11-13 Azarbarzin Kurt Director Conversion · Warrant (right to buy) +123,653 123,653
2019-11-13 Azarbarzin Kurt Director Conversion · Warrant (right to buy) −1,665 0
2019-11-13 Azarbarzin Kurt Director Conversion · Warrant (right to buy) +1,665 1,665
2019-11-13 PERSENAIRE MAARTEN Chief Medical Officer Conversion +7,999 66,127
2019-11-13 PERSENAIRE MAARTEN Chief Medical Officer Conversion +12,760 78,887
2019-11-13 PERSENAIRE MAARTEN Chief Medical Officer Conversion · Series A Preferred Stock −197,511 0
2019-11-13 PERSENAIRE MAARTEN Chief Medical Officer Conversion · Series B Preferred Stock −315,086 0
2019-11-13 PERSENAIRE MAARTEN Chief Medical Officer Conversion · Warrant (right to buy) −12,931 0
2019-11-13 PERSENAIRE MAARTEN Chief Medical Officer Conversion · Warrant (right to buy) +12,931 12,931
2019-11-13 Greenhalgh Ellis Skott Chief Science Officer Conversion +2,025 5,623
2019-11-13 Greenhalgh Ellis Skott Chief Science Officer Conversion +4,887 10,510
2019-11-13 Greenhalgh Ellis Skott Chief Science Officer Conversion · Series A Preferred Stock −50,000 0
2019-11-13 Greenhalgh Ellis Skott Chief Science Officer Conversion · Series B Preferred Stock −120,699 0
2019-11-13 Greenhalgh Ellis Skott Chief Science Officer Conversion · Warrant (right to buy) −1,976 0
2019-11-13 Greenhalgh Ellis Skott Chief Science Officer Conversion · Warrant (right to buy) +1,976 1,976
2019-11-13 Friedman Ashley Director Conversion +59,940 106,052
2019-11-13 Friedman Ashley Director Conversion +285,580 505,281

Page 27 of 29 · 565 trades